All said, it must also be appreciated that the presence of hyperprolactinemia is well documented to be associated with and potentiate metabolic syndrome and cardiovascular disease in animals and humans [132,133,134,135,136,137,138], which importantly, can be manifested via chronic prolactin inhibition of brain dopaminergic activity [139]. This evidence concerns the gene PRL and cardiovascular disorder.